Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CHE
CHE logo

CHE Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
435.700
Open
426.590
VWAP
432.05
Vol
224.62K
Mkt Cap
5.76B
Low
426.590
Amount
97.05M
EV/EBITDA(TTM)
13.80
Total Shares
13.27M
EV
5.71B
EV/OCF(TTM)
12.86
P/S(TTM)
2.37
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
Show More

Events Timeline

(ET)
2026-04-23
16:30:00
VITAS Raises 2026 Earnings Guidance to $24.00 to $24.75 per Share
select
2026-04-23
16:30:00
Chemed Reports Q1 Revenue of $657.5M
select
2026-04-01 (ET)
2026-04-01
10:30:00
Roto-Rooter Acquires Franchises in San Francisco and Fort Worth for $20.6M
select

News

Newsfilter
8.5
06-08Newsfilter
Chemed Acquires Texas Roto-Rooter Franchise for $12 Million
  • Acquisition Deal: Chemed Corporation has acquired a formerly independent Roto-Rooter franchise for approximately $12 million, covering 21 counties in South Texas, including cities like Corpus Christi, McAllen, Laredo, and Brownsville, thereby expanding its market presence.
  • Market Leadership: This acquisition is expected to enhance Chemed's service capabilities in Texas, as Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services, which may improve the company's overall business performance and customer base.
  • Strategic Implications: By integrating this franchise, Chemed aims to optimize resource allocation and enhance service efficiency, thereby maintaining a competitive edge in a crowded market and meeting the growing customer demand.
  • Future Outlook: Chemed's announcement includes caution regarding forward-looking statements, indicating that future performance may be influenced by various factors, urging investors to be aware of potential risks associated with these projections.
seekingalpha
6.5
06-03seekingalpha
Barington Capital Accumulates Stake in Chemed and Proposes New Director
  • Investor Stake Increase: Barington Capital has accumulated a stake in Chemed (CHE) and proposed former Cerberus Capital Management CEO Chan Galbato as a new board member, indicating confidence in the company's future prospects.
  • Management Discussions: Barington has engaged in talks with Chemed's management regarding the potential addition of a new director, highlighting its focus on corporate governance and possibly prompting strategic adjustments within the company.
  • Stock Price Reaction: Following the news, Chemed's stock rose by 2%, reflecting a positive market perception of Barington's involvement, despite a 27% decline in stock price over the past year.
  • Dividend Declaration: Chemed declared a dividend of $0.60 per share, demonstrating the company's ability to maintain cash flow and shareholder returns in the current market environment.
seekingalpha
8.0
05-19seekingalpha
Chemed Declares $0.60 Quarterly Dividend, Consistent with Previous Payments
  • Dividend Declaration: Chemed has declared a quarterly dividend of $0.60 per share, consistent with previous payments, indicating the company's stable cash flow and profitability, which enhances investor confidence.
  • Yield Metrics: The forward yield of 0.54% reflects the company's attractiveness in the current market environment, potentially drawing in more investors seeking stable income.
  • Payment Schedule: The dividend is payable on June 16, with a record date of May 28 and an ex-dividend date also on May 28, ensuring shareholders receive their returns promptly, thereby reinforcing shareholder loyalty.
  • Consistent Payout Record: Chemed has now announced a $0.60 dividend for four consecutive quarters, demonstrating the company's ongoing commitment to shareholder returns, which may enhance its market position within the healthcare sector.
Newsfilter
8.0
05-18Newsfilter
Chemed Corporation Elects Directors and Declares Dividend at 2026 Annual Meeting
  • Board Election: At the 2026 annual meeting, Chemed Corporation's shareholders elected a slate of nine directors, ensuring stability in the governance structure and supporting future strategic decision-making.
  • Auditor Reappointment: Shareholders unanimously ratified the continuation of PricewaterhouseCoopers as the independent accountants for 2026, reflecting a commitment to financial transparency and compliance, which enhances investor confidence.
  • Shareholder Proposal Rejection: The non-binding proposal regarding executive compensation was not approved, indicating shareholder scrutiny over the company's executive pay policies, which may prompt a review and adjustment of compensation structures in the future.
  • Quarterly Cash Dividend: The Board declared a cash dividend of 60 cents per share, payable on June 16, 2026, marking the 220th consecutive quarterly dividend, which underscores Chemed's consistent profitability and commitment to shareholder returns over its 55-year history.
seekingalpha
8.0
05-13seekingalpha
U.S. Temporarily Blocks New Home Health Providers from Medicare Enrollment
  • New Medicare Regulations: The U.S. government plans to temporarily block new home health and hospice providers from enrolling in Medicare on Wednesday, reflecting a stringent regulatory approach to combat fraud linked to government-backed healthcare programs.
  • Nationwide Moratorium: This nationwide pause aims to address healthcare scams, particularly those affecting Medicare, and is expected to enhance transparency and compliance within the healthcare service sector.
  • Anti-Fraud Task Force Actions: Vice President JD Vance's anti-fraud task force will announce several policy changes, emphasizing the crackdown on large-scale fraud, which aims to protect the interests of the American public and demonstrates a zero-tolerance stance towards healthcare fraud.
  • Industry-Wide Impact: This move could significantly affect major home health and hospice providers, including BrightSpring Health Services and UnitedHealth, prompting companies within the industry to strengthen compliance measures in response to the new regulatory environment.
seekingalpha
9.5
05-12seekingalpha
Chemtrade Logistics Income Fund Reports Q1 Earnings Decline
  • Net Earnings Decline: Chemtrade Logistics Income Fund reported Q1 net earnings of C$25.4 million, a significant decrease of C$23.7 million year-over-year, primarily due to rising finance costs and unfavorable unrealized foreign exchange losses, indicating financial pressure on the company.
  • Revenue Performance: The total revenue for Q1 reached C$503 million, showing growth compared to the previous year; however, this increase was insufficient to offset the rising costs, reflecting intensified market competition.
  • Adjusted EBITDA Decrease: Adjusted EBITDA stood at C$113.5 million, down C$6.6 million or 5.5% year-over-year, highlighting challenges in profitability that may impact future investment decisions.
  • Impact of Financial Costs: The significant impact of rising finance costs and foreign exchange losses on Chemtrade's financial condition raises concerns among investors regarding the company's future growth potential.
Wall Street analysts forecast CHE stock price to rise
3 Analyst Rating
Wall Street analysts forecast CHE stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
475.00
Averages
547.33
High
595.00
Current: 0.000
sliders
Low
475.00
Averages
547.33
High
595.00
RBC Capital
Sector Perform
maintain
$422 -> $436
AI Analysis
2026-04-27
Reason
RBC Capital
Price Target
$422 -> $436
AI Analysis
2026-04-27
maintain
Sector Perform
Reason
RBC Capital raised the firm's price target on Chemed to $436 from $422 and keeps a Sector Perform rating on the shares. Shares rallied over 10% on Friday following a solid Q1 print and a rare post-Q1 guidance raise, with VITAS delivering strong census growth and margin outperformance that drove consolidated EBITDA and EPS well above consensus, the analyst tells investors in a research note.
Oppenheimer
Oppenheimer
maintain
$500
2026-03-31
Reason
Oppenheimer
Oppenheimer
Price Target
$500
2026-03-31
maintain
Reason
Oppenheimer still believes Chemed can unlock Roto-Rooter's value operationally. However, it makes sense to looking at the value of the two companies separately given their lack of synergies and changes to the business, the analyst tells investors in a research note. Oppenheimer applied a 12-18 times multiple on the Roto-Rooter business, equating to $2.3B to $3.5B. Potential value can be unlocked by splitting up the companies, contends the firm. Its analysis puts the total value of Chemed at a $5.6B to $7.8B enterprise value, which translates to $426-$588 per share, or upside potential of 16%-59% from current levels. As such, the analyst recommends being long-term buyer of the stock. Oppenheimer has an Outperform rating on Chemed with a $500 price target. The stock in morning trading is up 1% to $378.27.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CHE
Unlock Now

Valuation Metrics

The current forward P/E ratio for Chemed Corp (CHE.N) is 17.33, compared to its 5-year average forward P/E of 23.17. For a more detailed relative valuation and DCF analysis to assess Chemed Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
23.17
Current PE
17.33
Overvalued PE
25.93
Undervalued PE
20.42

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
15.72
Current EV/EBITDA
13.36
Overvalued EV/EBITDA
17.49
Undervalued EV/EBITDA
13.94

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.17
Current PS
1.95
Overvalued PS
3.67
Undervalued PS
2.68

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

current bullish rsi divergences
Intellectia · 213 candidates
Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
NVO logo
NVO
Novo Nordisk A/S
170.38B
MELI logo
MELI
MercadoLibre Inc
89.62B
NTES logo
NTES
NetEase Inc
73.21B
ET logo
ET
Energy Transfer LP
63.96B
BIDU logo
BIDU
Baidu Inc
45.60B
TCOM logo
TCOM
Trip.com Group Ltd
35.00B
for a binnger
Intellectia · 22 candidates
Beta: LowRiskDebt Equity: <= 1Weekly Average Turnover: >= 1,000,000Annual Eps Yoy Growth: >= 0.0%Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TW logo
TW
Tradeweb Markets Inc
24.53B
ERIE logo
ERIE
Erie Indemnity Co
14.64B
JKHY logo
JKHY
Jack Henry & Associates Inc
13.59B
DT logo
DT
Dynatrace Inc
11.88B
EPAM logo
EPAM
Epam Systems Inc
11.76B
NYT logo
NYT
New York Times Co
11.51B

Whales Holding CHE

A
Aptus Capital Advisors, LLC
Holding
CHE
+14.26%
3M Return
B
Bridges Investment Management Inc
Holding
CHE
+13.66%
3M Return
A
Aristotle Capital Boston, LLC
Holding
CHE
+12.89%
3M Return
C
Copeland Capital Management, LLC
Holding
CHE
+12.09%
3M Return
I
Integrated Wealth Concepts LLC
Holding
CHE
+11.36%
3M Return
B
Boston Trust Walden Company
Holding
CHE
+10.19%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Chemed Corp (CHE) stock price today?

The current price of CHE is 433.87 USD — it has increased 2.45

What is Chemed Corp (CHE)'s business?

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

What is the price predicton of CHE Stock?

Wall Street analysts forecast CHE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHE is547.33 USD with a low forecast of 475.00 USD and a high forecast of 595.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Chemed Corp (CHE)'s revenue for the last quarter?

Chemed Corp revenue for the last quarter amounts to 657.51M USD, increased 1.63

What is Chemed Corp (CHE)'s earnings per share (EPS) for the last quarter?

Chemed Corp. EPS for the last quarter amounts to 4.84 USD, decreased -0.41

How many employees does Chemed Corp (CHE). have?

Chemed Corp (CHE) has 15811 emplpoyees as of June 17 2026.

What is Chemed Corp (CHE) market cap?

Today CHE has the market capitalization of 5.76B USD.